Summary: Serum uric acid levels measured by the phosphotungstic sodium cyanide method have been estimated in 60 patients suffering from a cerebrovascular incident. Patients with diseases known to predispose to hyperuricaemia were excluded. Twenty-five per cent. of patients with acute strokes had hyperuricaemia, and this did not appear to be a transitory phenomenon. These findings suggest that hyperuricaenia may be one of the factors in the pathogenesis of atheroma.
Introduction
The high incidence of atherosclerosis in patients suffering from gout has been known since the last century (Futcher, Osler, and McCrae, 1907) . The increased incidence of hyperuricaemia in patients with coronary heart disease has been shown by Gertler, Gamn, and Levine (1951) , Kohn and Prozan (1959) , and Dreyfuss (1960) . More recently Breckenridge (1966) showed a significant relationship between hyperuricaemia and hypertension. Despite these important findings, little attention has been paid to the possible relation between hyperuricaemia and atherosclerotic and hypertensive disease of the cerebral vascular tree. Hansen (1965) found significant hyperuricaemia in 36% of 115 patients with acute cerebral infarction. Meyer, Kypros, and Gilroy (1964) found byperuricaemia in 32% of 59 patients suffering from cerebrovascuilar disease.
A wider range of normal values has recently been established by epidemiological studies (Kellgren, 1964) , and further investigation seemed indicated to validate the possible association of raised plasma uric acid levels and cerebrovascular disease.
Material and Methods
An unselected series of 60 consecutive patients with "strokes " admitted to the Combined Neurological Service and to the general medical wards at the Hull Royal Infirmary were investigated. Most of these patients were referred to the hospital as emergencies for an acute completed cerebrovascular episode, while some were admitted for investigations of recurrent transient cerebral ischaemic attacks.
The diagnosis of cerebral vascular disease was based on a detailed clinical examination, supplemented by contrast radiological studies in 19 selected patients (32%). Conditions such as hyperthyroidism, hypothyroidism, polycythaemia, and other blood dyscrasias and dysproteinaemias were excluded, since these are known to alter uric acid levels. The presence of hypertension (diastolic pressure greater than 100 mm. Hg), diabetes mellitus, and antihypertensive treatment was specially noted. In addition to routine laboratory tests, measurements of serum uric acid, blood urea, and serum creatinine 'were carried out in Fig. 3 ). Blood samples were taken in the morning while the patients were fasting.
Serum uric acid was determined by the phosphotungstic sodium cyanide method (Pearson, Sterm, and Mackett, 1953) 
Results
Two hundred control subjects were examined for serum uric acid levels-; gout, treatment with diuretics or hypotensive drugs, thyroid disorders, severe hypertension, dysproteinaemias, and renal failure were excluded. The mean age of the 124 men was 54 years, and of the 76 women 66 years. These subjects are comparable to the series of patients with cerebrovascular disease.
Statistical analysis of the controls shows no trend for uric acid levels in respect of age or sex, though values in males are slightly higher, as in other series: Males: mean serum uric acid=5-28 mg./100 ml., S.D.=0 66; mean+2 S.D.s=6 60. Females: mean serum uric acid=4-47 mg./100 ml., S.D.= 0 78; mean+2 S.D.s= 603.
In this study values of 7 mg./100 ml. in males and 6 mg./ 100 ml. in females are therefore regarded as abnormal. These correspond to the values of Henry (1960) and Kellgren (1964) .
The study included 57 patients (95%) with cerebral infarction and 3 (5%) with cerebral haemorrhage. There were 41 men with a mean age of 55 and 19 women with a mean age of 68. The different ages in each sex reflect the general trend for strokes to occur at older ages in women. Fig. 1 shows that nine men had serum uric levels of 7 mg./ 100 ml. or more, an incidence of 22 %, and that six women had uric acid levels of 6 mg./100 ml. or more, an incidence of 33%. Fig. 1 Since patients with moderate or advanced renal failure were deliberately excluded, a valid comparison of uric acid levels with blood urea (see Fig. 3 ) was not possible. Nevertheless, of six patients with blood urea levels between 45 and 120 mg./ 100 ml., four had hyperuricaemia. Similarly no valid comparison with serum creatinine levels (see Fig. 4 ) was possible in view of the small number of patients with creatinine levels greater than 1-7 mg./100 ml. The exclusion of patients with gross renal failure was deliberate, and was designed to eliminate hyperuricaemia secondary to this factor, which might otherwise contribute to a falsely high incidence in this series. Discussion Reference has already been made to the association of raised uric acid levels in gout, coronary artery disease, and hypertension. Hyperuricaemia has also been demonstrated after the administration of diuretics and ganglion blocking drugs (Dollery, Duncan, and Schumer, 1960) . Reports of raised serum uric acid levels in myxoedema, toxaemia of pregnancy, diabetes, psoriasis, multiple myeloma, renal failure, and mongolism have been summarized by Meyer et al. (1964) .
The normal values of serum uric acid levels quoted in the literature have varied according to the method employed. Further, variations occur in relation to the total calorie intake and to the fat and the purine content of the diet, and there is a diurnal variation (Henry, 1960; Kellgren, 1964) .
The results of the present study show that, despite wide normal variations for serum uric acid, a significant proportion of patients with cerebral infarction or cerebral haemorrhage show hyperuricaemia. This was found in 25% of patients in this study, and affects both sexes. These results are similar to those of Hansen (1965) and Meyer et al. (1964) , who found hyperuricaemia in respectively 36% and 32% of their patients with cerebrovascular disease. Older and less accurate methods for estimating uric acid were used in these studies. From our own series patients with significant clinical renal failure were deliberately excluded. In patients with normal serum creatinine and blood urea levels, and in those with only slight rises in these measurements of renal function, there was no significant correlation between mild azotaemia and raised uric acid levels. Similarly, hypertension did not in itself predispose to hyperuricaemia in our series, but it is probable (Breckenridge, 1966) that sustained severe hypertension may be an important factor; this was not, however, apparent in the present study. It seemed possible that raised uric acid levels might be a transitory phenomenon after a cerebral infarct or haemorrhage, but examination of this hypothesis excluded it as an explanation for the hyperuricaemia (Fig. 5) . Further, serial estimations after a stroke showed only occasional and rather wide variation, but no distinctive pattern emerged.
It seems, therefore, that primary hyperuricaemia, in the absence of gout or any other known predisposing cause, is present in a significant proportion of patients with cerebral infarction or haemorrhage. This suggests that hyperuricaemia may be one of many factors predisposing to Lhe genesis of atheroma and its sequelae in the cerebral vasculature. This suggestion correlates with the recent views that the renal lesion in gout is a "vascular nephrosclerosis" (Barlow and Beilin, 1968) .
There is no satisfactory explanation at present of the role of uric acid in the causation of atherosclerosis. Traut, Knight, and Szanto (1954) demonstrated the presence of urate crystals in the proliferated intima of coronary arteries and in organized thrombi. Since atheroma is a generalized process, this suggests one possible mechanism by which urate deposits might be the starting-point for progressive atherosclerotic disease. The other explanation was put forward by Gertler et al. (1951) . They suggested that uric acid, being a powerful cationic surface agent, could perhaps attach itself to the larger cholesterol molecule and bring it into contact with the arterial intima. In this way they envisaged the onset of atheroma. T[iis idea was further elaborated by Schrade, Boehle, and Biegil (1960) , who thought that atherosclerosis might be a " complex disturbance of biood lipid and other regulatory mechanisms," and thev felt that one of the factors involved was an abnormality in uric sc:Ad metabolism. Apart from these speculations, there is no evidence from experimental pathology to suggest a mechanism which might relate abnormal uric acid levels to atheroma. One possible mechanism might be via abnormalities of plasma lipids, and therefore a further study has been carried out which forms the subject of a separate report (Pearce and Aziz, 1969 Kiloh, Davison, and Osselton (1961) found that imipramine in therapeutic doses increased the frequency of attacks in epileptic patients, and that in large doses it precipitated attacks in non-epileptics, and occasionally therapeutic doses had the same effect. Amitriptyline, introduced in 1960, was found to have anticonvulsant properties in animals (Vernier, 1961) , and Winfield and Aivazian (1962) reported that this drug had no effect on the electroencephalogram (E.E.G.). Davison (1965) reported that intravenous amitriptyline had an activating action on paroxysmal activity in the E.E.G.s of 11 out of 20 epileptics, and two patients who had taken overdoses of the drug developed convulsions.
Betts, Kalra, Cooper, and Jeavons (1968) reported seven cases in which it appeared that amitriptyline was the probable cause of epileptic fits in depressed patients. They emphasized that this and other antidepressant drugs should be used with caution, especially in patients whose convulsive threshold might be low, and advised that such patients should be closely supervised,
